Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.09
-0.11 (-1.53%)
At close: Jan 30, 2026, 4:00 PM EST
7.06
-0.03 (-0.42%)
After-hours: Jan 30, 2026, 4:10 PM EST
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $47.88 million as of January 30, 2026. Its market cap has decreased by -65.37% in one year.
Market Cap
47.88M
Enterprise Value
53.13M
1-Year Change
-65.37%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $47.88M, a decrease of -98.10%. That is a compound annual growth rate of -55.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 47.88M | -35.82% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | 2.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 49.97M |
| Aligos Therapeutics | 49.66M |
| CEL-SCI | 48.77M |
| OS Therapies | 47.89M |
| Q32 Bio | 47.74M |
| CervoMed | 47.65M |
| ABVC BioPharma | 47.61M |
| iBio, Inc. | 47.22M |